X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4805) 4805
Book Review (376) 376
Publication (160) 160
Book Chapter (26) 26
Conference Proceeding (21) 21
Dissertation (3) 3
Book / eBook (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3113) 3113
alpha-glucosidase (1860) 1860
humans (1229) 1229
animals (1219) 1219
alpha-glucosidases - metabolism (1093) 1093
biochemistry & molecular biology (1009) 1009
α-glucosidase (892) 892
food science & technology (856) 856
chemistry, medicinal (853) 853
glycoside hydrolase inhibitors (808) 808
alpha-glucosidase inhibitors (681) 681
pharmacology & pharmacy (675) 675
male (639) 639
alpha-glucosidase inhibitor (628) 628
rats (627) 627
diabetes (609) 609
enzyme inhibitors - pharmacology (599) 599
chemistry, organic (566) 566
chemistry, applied (516) 516
enzymes (492) 492
acarbose (481) 481
glucosidase (472) 472
molecular structure (461) 461
glycoside hydrolase inhibitors - pharmacology (460) 460
mice (444) 444
in-vitro (437) 437
hypoglycemic agents - pharmacology (427) 427
plant extracts - pharmacology (423) 423
antioxidant (420) 420
kinetics (408) 408
antioxidants (401) 401
enzyme inhibitors - chemistry (401) 401
glycoside hydrolase inhibitors - chemistry (397) 397
amylase (389) 389
derivatives (377) 377
plant extracts - chemistry (376) 376
structure-activity relationship (371) 371
inhibition (359) 359
diabetes mellitus (356) 356
flavonoids (347) 347
alpha-glucosidases - chemistry (340) 340
analysis (338) 338
glucose (336) 336
plant sciences (334) 334
antioxidant activity (331) 331
chemistry, multidisciplinary (329) 329
α-glucosidase inhibitor (329) 329
alpha-amylase (322) 322
female (319) 319
inhibitors (319) 319
nutrition & dietetics (302) 302
alpha-glucosidase inhibition (301) 301
hyperglycemia (298) 298
polyphenols (284) 284
diabetes mellitus, type 2 - drug therapy (277) 277
alpha-amylases - antagonists & inhibitors (273) 273
α-amylase (269) 269
biotechnology & applied microbiology (263) 263
dose-response relationship, drug (258) 258
type 2 diabetes (258) 258
chemistry (249) 249
hypoglycemic agents - chemistry (247) 247
leaves (247) 247
hypoglycemic agents - therapeutic use (238) 238
amylases (226) 226
oxidative stress (225) 225
constituents (224) 224
α-glucosidase inhibition (223) 223
insulin (221) 221
extract (215) 215
molecular docking (213) 213
identification (209) 209
blood glucose - metabolism (207) 207
extracts (207) 207
antioxidants - pharmacology (203) 203
molecular docking simulation (197) 197
endocrinology & metabolism (191) 191
proteins (191) 191
glycoside hydrolase inhibitors - isolation & purification (180) 180
research (172) 172
purification (171) 171
alpha-amylases - metabolism (169) 169
saccharomyces cerevisiae - enzymology (164) 164
enzyme inhibitors - isolation & purification (162) 162
postprandial hyperglycemia (162) 162
antioxidants - chemistry (161) 161
inhibitory concentration 50 (160) 160
medicine, research & experimental (158) 158
glycosylation (156) 156
analogs (153) 153
integrative & complementary medicine (151) 151
acid (149) 149
organic chemistry (149) 149
middle aged (148) 148
health aspects (147) 147
plant leaves - chemistry (147) 147
metabolism (144) 144
alpha-glucosidases (142) 142
blood glucose - drug effects (141) 141
molecular sequence data (141) 141
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4723) 4723
Chinese (42) 42
Japanese (19) 19
French (15) 15
German (12) 12
Russian (9) 9
Spanish (5) 5
Czech (3) 3
Korean (3) 3
Hungarian (2) 2
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2014, Volume 16, Issue 8, pp. 761 - 765
We assessed the efficacy and safety of sitagliptin compared with α‐glucosidase inhibitor ( αGI ) in 120 of Japanese patients with type 2 diabetes mellitus (... 
type 2 diabetes | DPP‐IV | inhibitor | sulphonylureas | α‐glucosidase inhibitor | randomized trial | Type 2 diabetes | Randomized trial | α-glucosidase inhibitor | Sulphonylureas | DPP-IV inhibitor | VOGLIBOSE | MONOTHERAPY | HYPERGLYCEMIA | DOUBLE-BLIND TRIAL | alpha-glucosidase inhibitor | ENDOCRINOLOGY & METABOLISM | MELLITUS | Glycated Hemoglobin A - analysis | Triazoles - adverse effects | Glycoside Hydrolase Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Glycoside Hydrolase Inhibitors - therapeutic use | Male | Pyrazines - therapeutic use | Hypoglycemia - prevention & control | 1-Deoxynojirimycin - therapeutic use | Drug Therapy, Combination - adverse effects | Inositol - therapeutic use | Inositol - adverse effects | 1-Deoxynojirimycin - analogs & derivatives | Female | 1-Deoxynojirimycin - adverse effects | Sitagliptin Phosphate | Hypoglycemia - chemically induced | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Japan | Sulfonylurea Compounds - therapeutic use | Inositol - analogs & derivatives | Diabetes Mellitus, Type 2 - blood | Gastrointestinal Agents - therapeutic use | Pyrazines - adverse effects | Aged | Gastrointestinal Agents - adverse effects | Diabetes Mellitus, Type 2 - drug therapy | alpha-Glucosidases - metabolism | alpha-Glucosidases - chemistry | Index Medicus
Journal Article
Journal Article
Cardiovascular Diabetology, ISSN 1475-2840, 07/2014, Volume 13, Issue 1, pp. 110 - 110
Background: Alpha glucosidase inhibitor (GI) attenuates postprandial hyperglycemia (PPH) and reduces the risk of cardiovascular events in patients with... 
Dipeptidyl peptidase 4 (DPP-4) inhibitors | Endothelial function | Flow-mediated dilatation | Alpha glucosidase inhibitor | CD34 | PROGENITOR CELLS | DIPEPTIDYL PEPTIDASE-4 INHIBITOR | GLYCEMIC CONTROL | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | VASCULAR-DISEASE | FLOW-MEDIATED VASODILATION | GLUCAGON-LIKE PEPTIDE-1 | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | JAPANESE PATIENTS | CORONARY-ARTERY-DISEASE | Prospective Studies | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Endothelium, Vascular - drug effects | Glycoside Hydrolase Inhibitors - therapeutic use | Male | Pyrazines - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Endothelium, Vascular - physiology | Young Adult | Inositol - therapeutic use | Aged, 80 and over | Adult | Female | Sitagliptin Phosphate | Triazoles - therapeutic use | Inositol - pharmacology | Glycoside Hydrolase Inhibitors - pharmacology | Inositol - analogs & derivatives | Triazoles - pharmacology | Diabetes Mellitus, Type 2 - diagnosis | Aged | Diabetes Mellitus, Type 2 - drug therapy | Pyrazines - pharmacology | Urine | Oxidative stress | Peptides | Internal medicine | Colleges & universities | Cardiovascular disease | Dentistry | Medicine | Hyperglycemia | Hospitals | Coronary vessels | Diabetes | Acute coronary syndromes | Drug dosages | Pharmaceutical sciences | Pharmaceuticals | Index Medicus
Journal Article
Process Biochemistry, ISSN 1359-5113, 02/2018, Volume 65, pp. 228 - 232
Fermented Nutrient Broth (FNB) was found to be a potential source of antidiabetic drugs in the previous report. Thus, FNB was employed to isolate the active... 
α–glucosidase inhibitor | Diabetes | Microbial conversion | Paenibacillus sp | ENGINEERING, CHEMICAL | NEWLY ISOLATED STRAIN | 1-DEOXYNOJIRIMYCIN | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | alpha-glucosidase inhibitor | BIOCHEMISTRY & MOLECULAR BIOLOGY | PURIFICATION | FERMENTATION | IDENTIFICATION
Journal Article
Food Chemistry, ISSN 0308-8146, 01/2013, Volume 136, Issue 2, pp. 297 - 300
Journal Article
Journal of Clinical and Diagnostic Research, ISSN 2249-782X, 12/2013, Volume 7, Issue 12, pp. 3023 - 3027
Diabetes Mellitus (DM) is a morbid disease worldwide, with increasing incidence as time passes. It has macro-vascular and micro-vascular complications. The... 
Postprandial hyperglycaemia (PPHG) | Alpha glucosidase inhibitors (αGI) | Review
Journal Article
Journal Article
Journal Article